| Literature DB >> 35280297 |
Jing Li1, Hongwei Wen2,3, Shengpei Wang4,5, Yena Che6, Nan Zhang7, Lingfei Guo7.
Abstract
Purpose: The objective of this study was to evaluate whether altered gray matter volume (GMV) and white matter volume (WMV) are associated with the presence of cerebral microbleeds (CMBs) in cerebral small vessel disease (CSVD). Materials andEntities:
Keywords: cerebral microbleeds; cerebral small vessel disease; gray matter volume; multivariate pattern analysis; white matter volume
Year: 2022 PMID: 35280297 PMCID: PMC8904567 DOI: 10.3389/fneur.2022.819055
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1The processing pipeline of VBM-DARTEL analysis using Statistical Parametric Mapping software. DARTEL, diffeomorphic anatomical registration through exponentiated lie algebra; GRF, Gaussian random field.
Figure 2The flow chart of machine learning based multivariate pattern analysis (MVPA) and nested cross-validation pipeline used in our study. Permutation test was used to evaluate the significance of the classification performance for 5,000 times randomly.
Demographic and clinical characteristics of CSVD patients and controls.
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Gender | 16 M/10 F | 21 M/22 F | 17 M/22 F | 0.359χ2 | - | - | - |
| Age (y) | 67.08 ± 6.19 | 66.68 ± 5.16 | 63.93 ± 8.87 | 0.105 | - | - | - |
| Education (y) | 11.56 ± 2.81 | 11.33 ± 2.68 | 12.97 ± 3.53 | 0.041 | |||
| smoking | 10 (38.5%) | 9 (20.9%) | 10 (25.6%) | 0.275χ2 | - | - | - |
| Hypertension | 24 (92.3%) | 38 (88.3%) | 12 (30.8%) | <0.001χ2 | <0.001 | 0.600 | <0.001 |
| Treated Hypercholesterolaemia | 15 (57.7%) | 13 (30.2%) | 5 (12.8%) | 0.001χ2 | 0.024 | <0.001 | 0.057 |
| Diabetes Mellitus | 9 (34.6%) | 9 (20.9%) | 4 (10.3%) | 0.057χ2 | - | - | - |
| Amended CSVD score | 4 (2, 5.25) | 2 (1, 2) | 0 (0.0) | <0.001 | <0.001 | <0.001 | <0.001 |
| WMH | 2 (1, 3) | 1 (1, 2) | 0 (0.0) | <0.001 | <0.001 | 0.079 | <0.001 |
| Lacune | 14 (53.8%) | 3 (7.0%) | 0 (0.0%) | <0.001χ2 | <0.001 | <0.001 | 0.093 |
| MoCA | 25.48 ± 2.67 | 27.58 ± 0.85 | 29.22 ± 3.27 | <0.001 | <0.001 | 0.001 | 0.003 |
| AVLT | 54.80 ± 16.01 | 64.38 ± 9.02 | 67.83 ± 8.49 | <0.001 | <0.001 | <0.001 | 0.126 |
| SDMT | 23.96 ± 10.62 | 31.19 ± 7.55 | 41.95 ± 17.03 | <0.001 | <0.001 | 0.016 | <0.001 |
| SCWT | 186.67 ± 68.53 | 145.24 ± 26.82 | 134.77 ± 37.42 | <0.001 | <0.001 | <0.001 | N.S. |
| TMT-A+B | 332.92 ± 170.61 | 262.69 ± 74.01 | 208.58 ± 99.66 | <0.001 | <0.001 | 0.012 | 0.032 |
| TIV | 1.61 ± 0.13 | 1.56 ± 0.14 | 1.62 ± 0.16 | 0.187 | - | - | - |
χ2: chi-square test,
: one-way analysis of variance (ANOVA) test,
: Kruskal-Walllis test. WMH, white matter hyperintensities. MoCA, Montreal Cognitive Assessment; AVLT, sum of Rey auditory verbal learning test (N1-7); SDMT, symbol digit modalities test; SCWT, sum of Stroop color-word test (stroop1-3); TMT, the trail-making test; TMT A+B, sum of TMT-A and TMT-B; TIV, total intracranial volume; CSVD-c, CSVD with CMBs group; CSVD-n, CSVD without CMBs group; HC, control group; N.S., not significant.
Significant altered GMV and WMV among three groups.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
| ||||
|
| Right superior frontal gyrus, medial orbital | 271 | 5.17 | 1 | 43 | −2 |
| Right inferior frontal gyrus, triangular part | 22 | 4.18 | 50 | 24 | 1 | |
| Left anterior cingulate gyrus | 16 | 4.16 | 1 | 33 | 29 | |
| Left superior frontal gyrus, medial | 38 | 3.80 | −2 | 44 | 32 | |
|
| Right superior frontal gyrus, medial orbital | 267 | 4.82 | 1 | 48 | −3 |
| Left anterior cingulate gyrus | 16 | 4.36 | 1 | 32 | 30 | |
| Left superior frontal gyrus, medial | 58 | 5.09 | −2 | 44 | 32 | |
|
| Left superior frontal gyrus, medial | 50 | 4.88 | −11 | 52 | 18 |
No significant differences were found between the two CSVD groups.
CSVD-c, CSVD with CMBs; CSVD-n, CSVD without CMBs.
Cluster size: the number of voxels in the (identified significant) cluster. ANOVA and LSD post-hoc test in a pair-wise manner within the areas identified by ANOVA were used to identify the GMV and WMV changes between groups with Gaussian random field (GRF) multiple comparison corrections (voxel level p <0.001, cluster level p <0.05).
Figure 3Brain regions showing significantly decreased GMV in (A) CSVD-c group and (B) CSVD-n group (ANOVA and LSD post-hoc test with GRF correction, voxel level p < 0.001, cluster level p < 0.05), and (C) decreased WMV in CSVD-n group compared with control group.
The statistics for evaluating classification performance.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| |||||
|
| 84.62% | 76.92% | 89.74% | 0.857 | <0.05 |
|
| 76.92% | 69.23% | 82.05% | 0.817 | <0.05 |
|
| 86.15% | 80.77% | 89.74% | 0.926 | <0.05 |
|
| |||||
|
| 74.39% | 67.44% | 82.05% | 0.815 | <0.05 |
|
| 74.39% | 65.12% | 84.62% | 0.804 | <0.05 |
|
| 81.71% | 69.77% | 94.87% | 0.891 | <0.05 |
|
| |||||
|
| 68.12% | 57.69% | 74.42% | 0.770 | <0.05 |
|
| 79.71% | 73.08% | 83.72% | 0.815 | <0.05 |
|
| 81.16% | 69.23% | 88.37% | 0.881 | <0.05 |
ACC/SEN/SPE, accuracy/sensitivity/specificity; AUC, area under the ROC curve. P: p-values generated by non-parametric permutation testing with 5,000 randomizations.
Figure 4Receiver operating characteristic (ROC) curve for (A) CSVD-c vs. HC, (B) CSVD-n vs. HC, and (C) CSVD-c vs. CSVD-n classification problems. HC, healthy controls.
Figure 5Weight (per region) maps modeled by multi-kernel learning (MKL) combining GMV and WMV features. As a simple kernel model was implemented by MKL-SVM, the weights per voxel will be averaged (in absolute value) within each ROI as defined by AAL atlas. The regional MKL weights representing regional contribution to (A) CSVD-c vs. HC, (B) CSVD-n vs. HC, and (C) CSVD-c vs. CSVD-n classification problems were rendered on the ICBM152 template. Weights with lower (1% or less) contribution are not shown. HC, healthy controls.